Skip to reading Semaglutide cost guide Chapters Start here Care questions The care questions chapter Questions worth asking before joining. Put these beside the price question. Ask for clear answers about the person reviewing your health, the product and the care that follows. Jump within this chapter Health review License checks Pharmacy-made medicines Sales claims Results Unwanted effects Changes in care Does a form mean a prescription? A prescription depends on a health review by the person who would write it. Bring your medicine names, health history and questions to that discussion. Choosing a drug from a menu cannot replace that health review, says medical-board guidance adopted in May 2026. The guidance also requires a way for the patient to send questions back. That guidance, checked September 26, 2026, does not replace each state’s rules. Source note Medical boards: guidance on online prescribing How can I check the names? Get the full name of the person writing your prescription and the pharmacy’s name before paying. The state medical board holds public records of penalties for breaking medical rules, as well as doctors’ licenses. A separate state board of pharmacy holds the pharmacy’s record. Find your state’s board through the directory, then search the doctor’s name. Use the state you will physically be in when the visit takes place. If the person writing your prescription is not a doctor, ask for their job title and which state board checks their license. Food and Drug Administration is the long form of FDA, the US medicines regulator. Its pharmacy-search page leads to your state’s official record. A license record is one useful check, but it gives no proof of care quality. Source note Find the state medical board Find the state pharmacy license search What is a pharmacy-made medicine? A pharmacy or doctor makes or mixes medicine to order for a particular patient, replacing the version a drug company supplies ready-made. This is called a compounded medicine. At the September 26, 2026 check, these made-to-order medicines still lacked FDA approval. FDA has not reviewed their safety, how well they are made or how well they work before these medicines reach patients. A medicine prepared to order can meet a patient’s medical need left unfilled by an approved product, under the rules checked that day. For example, a ready-made product may need changing for a patient who is allergic to its dye. At that check date, federal law barred pharmacies filling named patients’ prescriptions from regularly making close copies of an available drug. The ban also covers making very large amounts of those copies. The exception is a medicine changed for a named patient in a way the person prescribing judges to make an important difference. Ask them to explain the change and why it matters for you. A lower price alone does not meet this exception. FDA ended the national semaglutide injection shortage on February 21, 2025. The injections remained off its shortage list on September 26, 2026. A brand-name medicine’s generic version carries FDA approval of its own. On September 26, 2026, no semaglutide generic had full FDA approval for US sale. Before comparing prices, ask whoever would write your prescription why this product suits your medical needs. Source note FDA: understanding medicines prepared to order FDA: shortage status and limits on copies Which sales claims call for a pause? As checked September 26, 2026, FDA warned about calling a made-to-order medicine a generic or claiming it works just like an approved drug. FDA also flags pharmacies offering prescription drugs without a prescription, or leaving no pharmacist available for questions. The agency cautions that a convincing-looking site can be a false storefront. Keep the license check beside the sales page. Ask who makes and sends the medicine. Source note FDA: misleading claims about compounds FDA: pharmacy signs worth checking Has semaglutide helped people lose weight? STEP 1 was the name of a study of semaglutide shots. The study’s adult participants had no diabetes; they had obesity, or excess weight alongside a health problem related to that weight. After 68 weeks, the semaglutide group’s average loss was 14.9% of body weight. People given dummy shots with no semaglutide lost an average of 2.4%. Both groups also had support with food and activity, and the drug’s maker paid for the study. These are group averages from a study, not a forecast of your result. Source note Read the weight-loss trial summary What problems can it cause? The official Wegovy (semaglutide) drug information is called its label. In the label checked September 26, 2026, common problems included feeling sick (nausea), vomiting, loose stools and trouble passing stools. A serious warning concerns pancreas inflammation: painful swelling that can cause severe belly pain, sometimes spreading to the back. The label describes pain that will not go away. Gallbladder disease, such as gallstones, is another serious problem in the label. The label’s strongest warning, called a boxed warning, concerns thyroid tumors: growths whose warning signs can include a neck lump. Other signs listed are trouble swallowing or breathing, or a hoarse voice that does not go away. These tumors showed up in mice and rats. Whether semaglutide causes those tumors in humans is unknown. The particular rare cancer named in this warning is medullary thyroid cancer. A history of that cancer, whether in you or your family, rules out semaglutide under the label. If you know of thyroid cancer in the family but not its type, ask for help checking the medical records. MEN 2 is the name of a rare condition that can be passed from parent to child. The label rules out semaglutide for people who have this condition. If the name means nothing to you, ask the person reviewing your health to check your records and known family diagnoses with you. A past severe allergy to an ingredient in the product also rules out use; semaglutide itself counts too. Bring pregnancy plans, other medicines and any upcoming operation to the health review. Ask how a new symptom will be checked between visits. Source note Wegovy label: unwanted effects and who cannot use it What if the budget stops working? Before joining, ask how care continues if the cost rises or the plan refuses payment. A later study followed some STEP 1 participants after treatment ended. In its semaglutide group, roughly two-thirds of the earlier weight loss came back over the next year. Ask the person writing your prescription what a change or pause would mean for your care. Keep that answer with the costs of follow-up. Source note Read the trial follow-up summary Return to the money questions Put the full bill together Keep reading, by question. Start with the basics What this care is, before the price question. Put the bill together Medicine, visits, tests and later care. Ask what the plan pays Private cover, Medicare and paying cash. Check the care behind it Names, products, evidence and questions. This cost guide helps you find the right questions; it offers neither clinic visits nor medicines. Back to the top